Additionally, SimCells carrying different regulation systems, such as the recA regulation system (activated by γ-radiation therapy for cancer), could be explored to control the safe release of anticancer drugs generated by SimCells in order to enhance the anticancer effects. This evidence concerns the gene RAD51 and cancer.